Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride and what is the scope of patent protection?
Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
is the generic ingredient in two branded drugs marketed by Haleon Us Holdings and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride has forty-three patent family members in nineteen countries.
One supplier is listed for this compound.
Summary for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
International Patents: | 43 |
US Patents: | 2 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
DailyMed Link: | chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
Generic Entry Dates for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride*:
Constraining patent/regulatory exclusivity:
Dosage:
SUSPENSION;ORAL |
Generic Entry Dates for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.